GGrantIndex
Sort

78,016 grants matching breast cancer

Studies of the fate of environmental contaminants in humans and animals

$933,414
Linda Birnbaum · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC

$933,338
Bing Zhang · Baylor College Of Medicine · U24 · FY2019 · CA

Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research

$933,101
Xihong Lin · Harvard School Of Public Health · R35 · FY2020 · CA

Epidemiology of the four most frequent cancers following breast cancer

$932,958
Kathleen E Malone · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA

Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells

$932,892
Esta Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

AN IN SITU TUMOR VACCINE TO STIMULATE ANTITUMOR IMMUNITY AGAINST BREAST CANCER

$932,350
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2025 · Defense Health Agency

Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy

$932,268
Daniel Rotroff · Cleveland Clinic Lerner Com-Cwru · R33 · FY2024 · NS

Regulation of stem cell development during tissue remodeling

$932,109
Yun-Bo Shi · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD

Development of a mobile and automated platform for multiplexed multi-modality imaging

$932,083
Ryan Gessner · Sonovol, Inc. · R44 · FY2018 · CA

Tissue Microarray Design and Development for Novel Gene and Gene Product Screeni

$932,044
David E Kleiner · Clinical Sciences · Z01 · FY2007 · CA

Symptom Management After Breast Cancer Surgery

$931,525
University Of California San Francisco · R01 · FY2005 · CA

TGF-betas in breast cancer progression

$931,521
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Mechanisms governing metastatic dormancy and reactivation

$931,198
Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2019 · CA

Cell Growth Control In Vivo by CEBPbeta and CEBPdelta

$931,129
Esta Sterneck · Basic Sciences · Z01 · FY2007 · CA

Stationary Anti-scatter Grids for Digital Breast Imaging

$931,101
Cha-Mei Tang · Creatv Microtech, Inc. · R44 · FY2009 · CA

Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research

$931,042
Xihong Lin · Harvard School Of Public Health · R35 · FY2021 · CA

NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1

$931,004
Steven R Alberts · Mayo Clinic Rochester · UG1 · FY2022 · CA

Targeted Fluorescence Imaging of Nerves for Surgical Guidance

$930,961
Cristina A Tan Hehir · General Electric Global Research Ctr · R01 · FY2011 · EB

Novel small molecules for protection against doxorubicin cardiotoxicity in TNBC

$930,592
Cathy A Swindlehurst · Novomedix, Inc. · R44 · FY2023 · HL

University of Pennsylvania Patient-derived Xenograft Development and Trials Center

$930,590
Martin Carroll · University Of Pennsylvania · U54 · FY2023 · CA

CLUE STUDIES--EVALUATING BIOMARKERS OF CARCINOGENESIS

$930,585
Johns Hopkins University · U01 · FY2004 · CA

SYSTEMS IMMUNOLOGY FOR BREAST CANCER

$930,581
The Garvan Institute Of Medical Research · · FY2021 · Defense Health Agency

Optimizing Implementation in Cancer Control: OPTICC

$930,532
Bryan J. Weiner · University Of Washington · P50 · FY2021 · CA

Evaluating Whether a Concurrent Retinoid X Receptor Agonist can Enhance the Efficacy of the HER2-IGFPB2-IGF1R Vaccine in Eliminating Existing Ductal Carcinoma in Situ and Preventing Progression of Inv

$930,464
Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2018 · CA

Integrated high throughput proteogenomic data analysis center for CPTAC

$930,291
Denkanikota R Mani · Broad Institute, Inc. · U24 · FY2016 · CA